International HEOR & HTA Director

Role Overview

• Responsible for development of HEOR & HTA strategy aligned with the product and access strategy, and delivery of impactful HEOR evidence and deliverables (e.g., GVD, JCA Dossier, Early HTA Briefing Books, Cost-effectiveness Models, Budget Impact Models, evidence synthesis, utility strategy, Indirect Treatment Comparisons, Patient Preference Studies, access-enabling Outcomes Research and studies, etc.)
• Ensure that access evidence needs are reflected in the pivotal clinical programs, phase 3b/4, RWE and integrated evidence plans to meet the needs of external experts and institutions involved in reimbursement, pricing, access, and healthcare systems decisions.
• Oversee timely delivery of value evidence required for prioritized markets to achieve reimbursement and other positive funding recommendations to ensure optimal access.
• Develop fit-for-purpose communication/dissemination strategies and effectively translate impactful HEOR evidence into value story.
• Build strong partnerships within International V&A, Global and International Medical Affairs, International TAs, Patient Engagement, Development, S&G, regional and country counterparts.
• Collaborate with global regulatory, therapy area policy and access colleagues in seeking early scientific advice from payer, policy maker, and regulatory agencies in prioritized countries.
• Build strong partnerships and network with thought leaders in the HEOR field and facilitate sharing of learnings to upskill and elevate the organization.
• Stay abreast of internal and external developments, trends and other dynamics that affect the HEOR and HTA domains and share learnings with team and the broader organization.
• Support HEOR & HTA LT in external engagement (with HTA bodies, policy makers, regulatory agencies, HEOR scientific groups) to shape the HTA environment, the HEOR field and inform the organization on opportunities and risks.
• As a member of the International HEOR & HTA team, display enterprise-wide strategic thinking and proactively contribute to the functional strategy and vision and represent the function on critical internal initiatives.
• Embrace change with a positive mindset and help implement the new structure and optimize the ways of working with a focus on agility, flexibility and efficiency.

Requirements

• Advanced Degree; preferably Ph.D., M.D., MBA, RPh or equivalent.
• 8+ years of pharmaceutical industry experience and minimal of 5 years of relevant HEOR-related experience.
• Subject matter expertise in the areas of HEOR, HTA and value demonstration.
• Deep understanding of HTA/Payer evidence requirements and decision-making dynamics in International Region (ex-US) for all HTA archetypes.
• Significant experience working in or with global or above-country multidisciplinary drug development.
• Strong knowledge of research methodology, statistical methods in the field of data analysis and considerable experience collaborating with quantitative scientists and analysts.
• Extensive cross-functional experience with an innovation-focused, agile mindset and strong project-management capabilities.
• Fluency in English (oral and written).

Benefits

• Novartis Life Handbook
• Commitment to Diversity & Inclusion: Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.